Crossmark

Metabolic dysfunction-associated steatotic liver disease increases the incidence of metachronous liver metastases from TNM stage 0–II colorectal cancer

Crossref DOI link: https://doi.org/10.1007/s12072-025-10870-y

Published Online: 2025-08-08

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qian, Xiangjun

Long, Guojie

Wang, Qian

Zhang, Kai

Liu, Yanna

Zhang, Lei

Xie, Jiancong

Zheng, Zheyu

Zhou, Jinxue

Zhang, Dawei

Ma, Chao

Zhuang, Hao

Hao, Xiaopei

Huang, Xiaoming

Pan, Weidong https://orcid.org/0000-0001-9519-7683
Funding

Funding for this research was provided by:

the National Key Clinical Discipline

the National Key Clinical Discipline Construction Project

National Natural Science Foundation of China (82403332)

Henan Provincial Science and Technology Research Plan Provincial and Ministerial Youth Project (SBGJ202403017)

Henan Provincial Science and Technology Research Plan Provincial and Ministerial Youth Project (SBGJ202403010)
License Information

Text and Data Mining valid from 2025-08-08

Version of Record valid from 2025-08-08
More Information

Article History

Received: 21 January 2025

Accepted: 27 June 2025

First Online: 8 August 2025

Declarations

:

: Xiangjun Qian, Guojie Long, Qian Wang, Kai Zhang, Yanna Liu, Lei Zhang, Jiancong Xie, Zheyu Zheng, Jinxue Zhou, Dawei Zhang, Chao Ma, Hao Zhuang, Xiaopei Hao, Xiaoming Huang and Weidong Pan state that there is no conflict of interest related to the study.

: Reviewed and approved by the ethics committee of the Sixth Affiliated Hospital of Sun Yat-sen University (Approval number 2021ZSLYEC-442).

Document is current

Any future updates will be listed below